We're excited to announce the combination of Berkeley Lights and IsoPlexis, bringing together the Beacon and IsoSpark platforms to form the premier functional cell biology company. Visit Site

Empowering Translational Genome Editing in Immunotherapy

Understand the power of T-cell polyfunctionality and how single-cell proteomics data drive CAR-T cell therapy research and development.

Your data is secure

We keep your personal information safe and do not share it with any third parties. By submitting this form, you agree to receive communications from IsoPlexis and accept our Privacy Policy. You may unsubscribe at any time.

What's Inside

In this we discuss:

How Single-cell Functional Proteomics is changing genome editing & engineering for cell immunotherapy
CRISPR cell therapy discovery using single-cell functional proteomics
Single-Cell Proteomics confirms engineered cell response in bioprocessing
Moving forward with gene-edited allogeneic cell therapy using single-cell profiling
A Deeper Look

More about this

Single-Cell Functional Proteomics and Genome Engineering

Engineered T cells hold immense potential for immunotherapy, and there are many ways to amend or create immunotherapies using gene editing.

New methods of characterizing gene-edited cells need to be implemented to accelerate therapeutic efficacy and outcomes, such as potency and reducing immune-related adverse events.

Download this eBook to learn how IsoPlexis’ Functional Proteomics is changing genome editing & engineering for cell immunotherapy.

Get the